eduKateSG · Why Science?
Follow a Class III device from evidence to approval and later change
Read FDA Premarket Approval records through PMA numbers, approval orders, SSEDs, labeling, clinical and nonclinical evidence, supplements and postapproval requirements.
Some high-risk medical devices require Premarket Approval. FDA describes PMA as its scientific and regulatory review process for evaluating the safety and effectiveness of Class III devices subject to this pathway.
The public PMA database connects a device and applicant with an application number, decision date, approval order, labeling and, where applicable, a Summary of Safety and Effectiveness Data. Those documents give a learner a route from status to evidence.
Did you know? The SSED is a detailed FDA summary of the safety and effectiveness data supporting an approval or denial decision for original PMAs and certain panel-track supplements. It is more informative than an approval date alone.
This guide teaches regulatory evidence reading. It does not recommend a medical device or replace current labeling and professional medical judgement.
Chapter index
Chapters 1–9: PMA identity, evidence and decisions
- 1. The PMA number anchors the application
- 2. PMA addresses Class III devices
- 3. Approval requires valid scientific evidence
- 4. The approval order records the decision
- 5. SSED explains the evidence basis
- 6. Labeling defines authorised use
- 7. Clinical study design matters
- 8. Nonclinical evidence supports device evaluation
- 9. Approval date is not every later change
Chapters 10–17: supplements, labeling and lifecycle oversight
- 10. PMA supplements cover important changes
- 11. Panel-track supplements can require substantial data
- 12. Amendments are not approvals
- 13. Postapproval requirements continue oversight
- 14. Withdrawal and denial are separate actions
- 15. Device versions need exact identification
- 16. Postmarket evidence can change understanding
- 17. PMA literacy supports health technology careers
Premarket Approval evidence is clearest when device, PMA number, approval order, labeling and safety-effectiveness summary travel together. An original PMA receives a P number that links the device, applicant, decision and public documents. This teaches learners to connect a regulatory conclusion with the evidence document supporting it.
Try this
Evidence question: Which PMA number applies? Answer in three parts: identify the visible field or file, explain how it bears on the question, and state the boundary of that evidence. Preserve the database’s own object names and accession rather than flattening everything into the word ‘data’.
Try this: Record it before reading supplements. Turn the result into a compact claim-evidence-reasoning note, then ask a partner to retrace it. Keep the identifier, retrieval date and source page in the note so the route can be repeated.
Evidence checkpoint
Record the evidence object for the pma number anchors the application, its identifier or version context, and one limit that must remain visible.
PMA is FDA’s scientific and regulatory review pathway for Class III devices subject to that requirement. FDA describes PMA as the scientific and regulatory review process for Class III devices subject to premarket approval requirements. It also prevents a supplement from being mistaken for a brand-new original PMA.
Try this
Evidence question: Which classification and risk context apply? Answer in three parts: identify the visible field or file, explain how it bears on the question, and state the boundary of that evidence. Preserve the database’s own object names and accession rather than flattening everything into the word ‘data’.
Try this: Use the product code and regulation. Turn the result into a compact claim-evidence-reasoning note, then ask a partner to retrace it. If a field is missing, write “not shown” and follow the official documentation rather than inventing a value.
Evidence checkpoint
Record the evidence object for pma addresses class iii devices, its identifier or version context, and one limit that must remain visible.
CHAPTER 3 OF 17 · Identify the application
3. Approval requires valid scientific evidence
Original approvals and supplements describe different stages in the life of an approved device. FDA evaluates whether submitted evidence provides reasonable assurance of safety and effectiveness for the device’s conditions of use. Dates and supplement numbers preserve the chronology.
Try this
Evidence question: Which evidence supports the labeled use? Answer in three parts: identify the visible field or file, explain how it bears on the question, and state the boundary of that evidence. Preserve the database’s own object names and accession rather than flattening everything into the word ‘data’.
Try this: Connect studies to the decision and labeling. Turn the result into a compact claim-evidence-reasoning note, then ask a partner to retrace it. Before comparing two records, check that their object types, methods, versions and units really align.
Evidence checkpoint
Record the evidence object for approval requires valid scientific evidence, its identifier or version context, and one limit that must remain visible.
CHAPTER 4 OF 17 · Identify the application
4. The approval order records the decision
Postapproval information matters because an approval record continues after the first decision. The approval order is the formal FDA action for the application. Conditions and dates need exact reading. Medical decisions require current labeling and professional advice.
Try this
Evidence question: What did FDA approve and when? Answer in three parts: identify the visible field or file, explain how it bears on the question, and state the boundary of that evidence. Preserve the database’s own object names and accession rather than flattening everything into the word ‘data’.
Try this: Cite the order rather than a marketing page. Turn the result into a compact claim-evidence-reasoning note, then ask a partner to retrace it. Finish by naming one supported statement and one stronger statement that still needs another evidence layer.
Evidence checkpoint
Record the evidence object for the approval order records the decision, its identifier or version context, and one limit that must remain visible.
Premarket Approval evidence is clearest when device, PMA number, approval order, labeling and safety-effectiveness summary travel together. The Summary of Safety and Effectiveness Data describes the device, indications, alternatives, studies, benefits, risks and decision basis for applicable original PMAs and panel-track supplements. This teaches learners to connect a regulatory conclusion with the evidence document supporting it.
Try this
Evidence question: Which SSED section supports the statement? Answer in three parts: identify the visible field or file, explain how it bears on the question, and state the boundary of that evidence. Preserve the database’s own object names and accession rather than flattening everything into the word ‘data’.
Try this: Save the file and page. Turn the result into a compact claim-evidence-reasoning note, then ask a partner to retrace it. Keep the identifier, retrieval date and source page in the note so the route can be repeated.
Evidence checkpoint
Record the evidence object for ssed explains the evidence basis, its identifier or version context, and one limit that must remain visible.
PMA is FDA’s scientific and regulatory review pathway for Class III devices subject to that requirement. Approved labeling states indications, warnings, contraindications, instructions and other information. It should match the application and revision. It also prevents a supplement from being mistaken for a brand-new original PMA.
Try this
Evidence question: Which label version applies? Answer in three parts: identify the visible field or file, explain how it bears on the question, and state the boundary of that evidence. Preserve the database’s own object names and accession rather than flattening everything into the word ‘data’.
Try this: Record its date and PMA context. Turn the result into a compact claim-evidence-reasoning note, then ask a partner to retrace it. If a field is missing, write “not shown” and follow the official documentation rather than inventing a value.
Evidence checkpoint
Record the evidence object for labeling defines authorised use, its identifier or version context, and one limit that must remain visible.
Original approvals and supplements describe different stages in the life of an approved device. PMA evidence can include clinical investigations with specified populations, endpoints, controls and follow-up. Results depend on those design boundaries. Dates and supplement numbers preserve the chronology.
Try this
Evidence question: Which population and endpoint were studied? Answer in three parts: identify the visible field or file, explain how it bears on the question, and state the boundary of that evidence. Preserve the database’s own object names and accession rather than flattening everything into the word ‘data’.
Try this: Build a method-result-limit table. Turn the result into a compact claim-evidence-reasoning note, then ask a partner to retrace it. Before comparing two records, check that their object types, methods, versions and units really align.
Evidence checkpoint
Record the evidence object for clinical study design matters, its identifier or version context, and one limit that must remain visible.
CHAPTER 8 OF 17 · Read the evidence basis
8. Nonclinical evidence supports device evaluation
Postapproval information matters because an approval record continues after the first decision. Bench, animal, biocompatibility, electrical, software, sterilisation and manufacturing evidence can answer different safety and performance questions. Medical decisions require current labeling and professional advice.
Try this
Evidence question: Which evidence layer supports this feature? Answer in three parts: identify the visible field or file, explain how it bears on the question, and state the boundary of that evidence. Preserve the database’s own object names and accession rather than flattening everything into the word ‘data’.
Try this: Name the test and acceptance criterion. Turn the result into a compact claim-evidence-reasoning note, then ask a partner to retrace it. Finish by naming one supported statement and one stronger statement that still needs another evidence layer.
Evidence checkpoint
Record the evidence object for nonclinical evidence supports device evaluation, its identifier or version context, and one limit that must remain visible.
Premarket Approval evidence is clearest when device, PMA number, approval order, labeling and safety-effectiveness summary travel together. The original decision date establishes the first approval under that PMA. Supplements and postapproval actions can change device design, manufacturing or labeling. This teaches learners to connect a regulatory conclusion with the evidence document supporting it.
Try this
Evidence question: Is this original approval or a supplement? Answer in three parts: identify the visible field or file, explain how it bears on the question, and state the boundary of that evidence. Preserve the database’s own object names and accession rather than flattening everything into the word ‘data’.
Try this: Use separate timeline rows. Turn the result into a compact claim-evidence-reasoning note, then ask a partner to retrace it. Keep the identifier, retrieval date and source page in the note so the route can be repeated.
Evidence checkpoint
Record the evidence object for approval date is not every later change, its identifier or version context, and one limit that must remain visible.
PMA is FDA’s scientific and regulatory review pathway for Class III devices subject to that requirement. FDA explains that a PMA supplement is required for certain changes affecting safety or effectiveness of an approved device. Supplement types and review paths vary. It also prevents a supplement from being mistaken for a brand-new original PMA.
Try this
Evidence question: Which change does the supplement address? Answer in three parts: identify the visible field or file, explain how it bears on the question, and state the boundary of that evidence. Preserve the database’s own object names and accession rather than flattening everything into the word ‘data’.
Try this: Read its supplement number and decision. Turn the result into a compact claim-evidence-reasoning note, then ask a partner to retrace it. If a field is missing, write “not shown” and follow the official documentation rather than inventing a value.
Evidence checkpoint
Record the evidence object for pma supplements cover important changes, its identifier or version context, and one limit that must remain visible.
CHAPTER 11 OF 17 · Follow supplements
11. Panel-track supplements can require substantial data
Original approvals and supplements describe different stages in the life of an approved device. Certain significant changes may follow panel-track review and receive their own safety-effectiveness summary. Dates and supplement numbers preserve the chronology.
Try this
Evidence question: What evidence was new? Answer in three parts: identify the visible field or file, explain how it bears on the question, and state the boundary of that evidence. Preserve the database’s own object names and accession rather than flattening everything into the word ‘data’.
Try this: Compare the supplement SSED with the original. Turn the result into a compact claim-evidence-reasoning note, then ask a partner to retrace it. Before comparing two records, check that their object types, methods, versions and units really align.
Evidence checkpoint
Record the evidence object for panel-track supplements can require substantial data, its identifier or version context, and one limit that must remain visible.
Postapproval information matters because an approval record continues after the first decision. An amendment adds information to a pending PMA or supplement or can include later correspondence. It should not be counted as a separate approved device. Medical decisions require current labeling and professional advice.
Try this
Evidence question: What procedural role does the filing have? Answer in three parts: identify the visible field or file, explain how it bears on the question, and state the boundary of that evidence. Preserve the database’s own object names and accession rather than flattening everything into the word ‘data’.
Try this: Preserve the database label. Turn the result into a compact claim-evidence-reasoning note, then ask a partner to retrace it. Finish by naming one supported statement and one stronger statement that still needs another evidence layer.
Evidence checkpoint
Record the evidence object for amendments are not approvals, its identifier or version context, and one limit that must remain visible.
CHAPTER 13 OF 17 · Connect postapproval information
13. Postapproval requirements continue oversight
Premarket Approval evidence is clearest when device, PMA number, approval order, labeling and safety-effectiveness summary travel together. Approved PMAs can carry annual-report, medical-device-reporting, surveillance or other requirements. This teaches learners to connect a regulatory conclusion with the evidence document supporting it.
Try this
Evidence question: Which requirement applies after approval? Answer in three parts: identify the visible field or file, explain how it bears on the question, and state the boundary of that evidence. Preserve the database’s own object names and accession rather than flattening everything into the word ‘data’.
Try this: Follow the postapproval record. Turn the result into a compact claim-evidence-reasoning note, then ask a partner to retrace it. Keep the identifier, retrieval date and source page in the note so the route can be repeated.
Evidence checkpoint
Record the evidence object for postapproval requirements continue oversight, its identifier or version context, and one limit that must remain visible.
CHAPTER 14 OF 17 · Connect postapproval information
14. Withdrawal and denial are separate actions
PMA is FDA’s scientific and regulatory review pathway for Class III devices subject to that requirement. FDA can deny or withdraw approval under defined processes. The public record and Federal Register notices provide context. It also prevents a supplement from being mistaken for a brand-new original PMA.
Try this
Evidence question: Which action and date are documented? Answer in three parts: identify the visible field or file, explain how it bears on the question, and state the boundary of that evidence. Preserve the database’s own object names and accession rather than flattening everything into the word ‘data’.
Try this: Avoid treating an inactive listing as self-explanatory. Turn the result into a compact claim-evidence-reasoning note, then ask a partner to retrace it. If a field is missing, write “not shown” and follow the official documentation rather than inventing a value.
Evidence checkpoint
Record the evidence object for withdrawal and denial are separate actions, its identifier or version context, and one limit that must remain visible.
CHAPTER 15 OF 17 · Connect postapproval information
15. Device versions need exact identification
Original approvals and supplements describe different stages in the life of an approved device. A PMA can cover models and later modifications. Trade names alone may not identify the configuration studied or approved. Dates and supplement numbers preserve the chronology.
Try this
Evidence question: Which model and software version apply? Answer in three parts: identify the visible field or file, explain how it bears on the question, and state the boundary of that evidence. Preserve the database’s own object names and accession rather than flattening everything into the word ‘data’.
Try this: Connect labeling, UDI and PMA documents. Turn the result into a compact claim-evidence-reasoning note, then ask a partner to retrace it. Before comparing two records, check that their object types, methods, versions and units really align.
Evidence checkpoint
Record the evidence object for device versions need exact identification, its identifier or version context, and one limit that must remain visible.
CHAPTER 16 OF 17 · Connect postapproval information
16. Postmarket evidence can change understanding
Postapproval information matters because an approval record continues after the first decision. MDRs, recalls, safety communications and postapproval studies add evidence after approval. Raw reports and regulatory actions have different meanings. Medical decisions require current labeling and professional advice.
Try this
Evidence question: Which postmarket source answers the question? Answer in three parts: identify the visible field or file, explain how it bears on the question, and state the boundary of that evidence. Preserve the database’s own object names and accession rather than flattening everything into the word ‘data’.
Try this: Build a linked lifecycle timeline. Turn the result into a compact claim-evidence-reasoning note, then ask a partner to retrace it. Finish by naming one supported statement and one stronger statement that still needs another evidence layer.
Evidence checkpoint
Record the evidence object for postmarket evidence can change understanding, its identifier or version context, and one limit that must remain visible.
CHAPTER 17 OF 17 · Connect postapproval information
17. PMA literacy supports health technology careers
Premarket Approval evidence is clearest when device, PMA number, approval order, labeling and safety-effectiveness summary travel together. Biomedical engineers, statisticians, clinicians and regulatory scientists contribute different evidence to PMA review and follow-up. This teaches learners to connect a regulatory conclusion with the evidence document supporting it.
Try this
Evidence question: Which discipline produced this evidence? Answer in three parts: identify the visible field or file, explain how it bears on the question, and state the boundary of that evidence. Preserve the database’s own object names and accession rather than flattening everything into the word ‘data’.
Try this: Create a PMA document map. Turn the result into a compact claim-evidence-reasoning note, then ask a partner to retrace it. Keep the identifier, retrieval date and source page in the note so the route can be repeated.
Evidence checkpoint
Record the evidence object for pma literacy supports health technology careers, its identifier or version context, and one limit that must remain visible.
Contents · Previous chapter · Continue at the Science Learning Hub
An approval record becomes a science lesson when the decision stays linked to its evidence
The PMA database can show how FDA connected device identity, submitted evidence, labeling and a regulatory decision. Supplements and postapproval requirements keep the lifecycle visible after initial approval.
Save the PMA and supplement numbers, device and applicant, product code, approval order, SSED section, study design, benefit-risk findings, label revision, decision date, postapproval requirement and access date.
| Reading object | What it can support | Question to keep visible |
|---|---|---|
| PMA number | Identity of the premarket approval application | Which device and decision? |
| Approval order | Formal FDA action | What conditions and date apply? |
| SSED | Summary of safety and effectiveness evidence | Which study or risk supports the claim? |
| PMA supplement | Approved or pending change to the device record | What changed from the original? |
Sources and next reading
Substantive resource claims in this article were checked against the primary pages below. A structured record is a route into evidence; it does not by itself prove a scientific conclusion. Recheck the live record, evidence labels and release context before using it in assessed work or research.
For a classroom enquiry, save a short research receipt containing the question, search terms, selected object, exact identifier, version, access date and the evidence boundary you observed. Add the file or page that supports each statement. This small routine turns browsing into accountable science learning and gives a teacher, classmate or future analyst a route they can independently follow.
Before sharing the conclusion, ask another reader to retrace the route without verbal hints. If they reach a different version, file or interpretation, improve the receipt and narrow the claim. Reproducibility begins with this practical check. It teaches careful reading, supports fair collaboration and keeps uncertainty visible while evidence moves from an online service into notes, analysis and a final explanation.
A useful final review separates five questions. What object was found? Which organisation or repository maintains it? What exact evidence was inspected? Which statement does that evidence support? What remains uncertain? Answer each question in one sentence, then connect every answer to a visible field, file or source page. This review catches common mistakes: citing a collection when a file supplied the value, treating the newest release as the analysed release, confusing permission with scientific suitability, or turning a discovery count into a conclusion. It also gives students a calm way to improve work. A missing detail becomes a next research step instead of an invitation to guess. When the route is complete, the final explanation can stay simple because the identifiers, dates, versions, limitations and supporting evidence are already organised underneath it.
Primary sources
- FDA PMA database — accessed 25 October 2026.
- Premarket Approval overview — accessed 25 October 2026.
- PMA application contents and SSED — accessed 25 October 2026.
- PMA review process — accessed 25 October 2026.
- PMA supplements and amendments — accessed 25 October 2026.